Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures

Transfusion

Volumn 52, Issue SUPPL. 1, 2012, Pages

  Desborough, Michael ^a   Stanworth, Simon ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; HEMOSTASIS; HUMAN; INVASIVE PROCEDURE; LABORATORY TEST; OPERATING ROOM; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PREDICTIVE VALUE; PROTHROMBIN TIME; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STANDARD; THROMBOCYTE COUNT; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY;

ALGORITHMS; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; HEMORRHAGE; HUMANS; OPERATING ROOMS; PLASMA; POINT-OF-CARE SYSTEMS; SURGERY, COMPUTER-ASSISTED;

EID: 84861140985     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03691.x     Document Type: Article

References (55)

1. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM, British Committee for Standards in Haematology; Blood Transfusion Taskforce. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
2. Pamphilon DH,. Viral inactivation of FFP. Br J Haematol 2000; 109: 680-93.
3. Pelletier JP, Transue S, Snyder EL,. Pathogen inactivation techniques. Best Prac Res Clin Haematol 2006; 19: 205-42.
4. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2010. Manchester (UK): SHOT Office. 2011. [cited 2012 Apr 24]. Available from: URL http://www.shotuk.org/wp-content/uploads/2011/10/ SHOT-2010-Report1.pdf
5. Whitaker BI, Schlumpf K, Schulman J, Green. J, Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. Washington DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health, 2011.
6. Dzik W, Rao A,. Why do physicians request fresh frozen plasma? Transfusion 2004; 44: 1393-4.
7. Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF, Allard S,. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51: 62-70.
8. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D,; Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15: R108.
9. Dzik WH,. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3: 324-30.
10. Burns ER, Goldberg SN, Wenz B,. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 1993; 100: 94-8.
11. Keeling D,. International normalised ratio in patients not on vitamin K antagonists. J Thromb Haemost 2007; 5: 188-9.
12. Deitcher SR,. Interpretation of the international normalized ratio in patients with liver disease. Lancet 2002; 359: 47-8.
13. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P,. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-8.
14. Segal JB, Dzik WH,. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-25.
15. Callum JL, Dzik WH,. The use of blood components prior to invasive bedside procedures: a critical appraisal. In:, Mintz PD, editor. Transfusion therapy: clinical principles and practice. 3rd ed. Bethesda (MD): American Association of Blood Banks Press; 2010. p. 1-35.
16. Haas B, Chittams JL, Trerotola SO,. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. J Vasc Interv Radiol 2010; 21: 212-7.
17. Foster PF, Moore LR, Sankary HN, Hart ME, Ashmann MK, Williams JW,. Central venous catheterization in patients with coagulopathy. Arch Surg 1992; 127: 273-5.
18. Mumtaz H, Williams V, Hauer-Jensen M, Rowe M, Henry-Tillman RS, Heaton K, Mancino AT, Muldoon RL, Klimberg VS, Broadwater JR, Westbrook KC, Lang NP,. Central venous catheter placement in patients with disorders of hemostasis. Am J Surg 2000; 180: 503-5.
19. Doerfler ME, Kaufman B, Goldenberg AS,. Central venous catheter placement in patients with disorders of hemostasis. Chest 1996; 110: 185-8.
20. Carino GP, Tsapenko AV, Sweeney JD,. Central line placement in patients with and without prophylactic plasma. J Crit Care 2012 Feb 14. [Epub ahead of print]
21. Stafford-Smith M,. Impaired haemostasis and regional anaesthesia. Can J Anaesthesiol 1996; 43: R129-41.
22. Ruff RL, Dougherty JH,. Complications of lumbar puncture followed by anticoagulation. Stroke 1981; 101: V141-54.
23. Schramm B, Leslie K, Myles PS, Hogan CJ,. Coagulation studies in pre-operative neurosurgical patients. Anaesth Intensive Care 2001; 29: 388-92.
24. Darcy MD, Kanterman RY, Kleinhgoffer MA, Vesely TM, Picus D, Hicks ME, Pilgram TK,. Evaluation of coagulation tests as predictors of angiographic bleeding complications. Radiology 1996; 198: 741-4.
25. Tiroch KA, Arora N, Matheny ME, Liu C, Lee TC, Resnic FS,. Risk predictors of retroperitoneal haemorrhage following percutaneous coronary intervention. Am J Cardiol 2008; 102: 1473-6.
26. Farouque HM, Tremmel JA, Raissi Shabari F, Aggarwal M, Fearon WF, Ng MK, Rezaee M, Yeung AC, Lee DP,. Risk factors for the development of retroperitoneal haematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 2005; 45: 363-8.
27. Tripodi A, Mannucci PM,. The coagulopathy of chronic liver disease. NEJM 2011; 365: 147-56.
28. Gilmore IT, Burroughs A, Murry-Lyon IM, Williams R, Jenkins D, Hopkins A,. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians. Gut 1995; 36: 437-41.
29. McGill DB, Rakela J, Zinsmeister AR, Ott BJ,. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-400.
30. McVay PA, Toy PT,. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990; 94: 747-53.
31. Caturelli E, Squillante MM, Andriulli A, Siena DA, Cellerino C, De Luca F, Marzano MA, Pompili M, Rapaccini GL,. Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 1993; 13: 270-3.
32. Ewe K,. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 388-93.
33. McVay PA, Toy PT,. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991; 31: 164-71.
34. Bass J, White DA,. Thoracentesis in patients with hematologic malignancy: yield and safety. Chest 2005; 127: 2101-5.
35. Lin CH, Shih FY, Ma MH, Chiang WC, Yang CW, Ko PC,. Should bleeding tendency deter abdominal paracentesis? Dig Liver Dis 2005; 37: 946-51.
36. Webster ST, Brown KL, Luchey MR, Nostrant TT,. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol 1996; 91: 366-8.
37. Grabau CM, Crago SF, Hoff LK, Simon JA, Melton CA, Ott BJ, Kamath PS,. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004; 40: 484-8.
38. Veelo DP, Vlaar AP, Dongelmans DA, Binnekade JM, Levi M, Paulus F, Berends F, Schultz MJ,. Correction of subclinical coagulation disorders before percutaneous dilational tracheotomy. A randomized controlled trial. Blood Transfus 2012; 13: 1-8.
39. Wahl MJ,. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610-6.
40. Dietrich W, Dilthey G, Spannagl M, Richter JA,. Warfarin pretreatment does not lead to increased bleeding tendency during cardiac surgery. J Cardiothorac Vasc Anesth 1995; 9: 250-4.
41. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF,. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-52.
42. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M,. Is fresh frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012 Jan 18. [Epub ahead of print]
43. Abdel-Wahab OI, Healy B, Dzik WH,. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-85.
44. Holland LL, Brooks JP,. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-9.
45. Williamson LM, Llewelyn CA, Fisher NC, Allain JP, Bellamy MC, Baglin TP, Freeman J, Klinck JR, Ala FA, Smith N, Neuberger J, Wreghitt TG,. A randomized trial of solvent/detergent treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999; 39: 1227-34.
46. Cardigan R, Lawrie AS, Mackie IJ, Williamson LM,. The quality of fresh frozen plasma produced from whole blood stored at 4°C overnight. Transfusion 2005; 45: 1342-8.
47. Garwood M, Cardigan RA, Drummond O, Hornsey VS, Turner CP, Young D, Williamson LM, Prowse CV,. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh frozen plasma. Transfusion 2003; 43: 1238-47.
48. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW,. Efficacy of standard dose and 30 mL/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
49. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA,; TRALI Study Group. Transfusion related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-67.
50. Narick C, Triulzi DJ, Yazer MH,. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012; 52: 160-5.
51. Turner ML, Ludlam CA,. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 2009; 49: 14-23.
52. Lin Y, Stanworth S, Birchall J, Doree C, Hyde C,. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2011;(2):CD005011.
53. Levy HJ,. Pharmacologic methods to reduce perioperative bleeding. Transfusion 2008; 48: S31-8.
54. Tinmouth A, Macdougall L, Fergusson D, Amin M, Graham ID, Hebert PC, Wilson K,. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med 2005; 25: 845-52.
55. Tavares M, DiQuattro P, Nolette N, Conti G, Sweeney J,. Reduction in plasma transfusion after enforcement of transfusion guidelines. Transfusion 2011; 51: 754-61.